Rakesh K. Jain, PhD, A.W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and director of EL Steele Laboratory for Tumor Biology at the Massachusetts General Hospital Cancer Center in Boston, for creating a novel approach to imaging technologies in cancer research that has provided insights into tumor barriers and how to overcome them.
Rowan T. Chlebowski, MD, PhD, chief of Medical Oncology and Hematology at the Harbor-UCLA Medical Center and researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center in California, for leading reports on estrogen alone and estrogen plus progestin influence on cancer endpoints, which have substantially changed clinical use of menopausal hormone therapy worldwide with associated reduction in breast cancer incidence.
Monica Morrow, MD, chief of the Breast Surgery Service, co-chief of the Breast Program, and Anne Burnett Windfohr Chair of Clinical Oncology at Memorial Sloan-Kettering Cancer Center in New York City, for her distinguished record of accomplishments in advancing the field of breast cancer research.
Matti S. Aapro, MD, dean of the Multidisciplinary Oncology Institute in Genolier, Switzerland, and executive director of the International Society of Geriatric Oncology (SIOG), for his work as an active researcher in new drug development, breast cancer, cancer in the elderly, and supportive care.
Ching-Hon Pui, MD, chair of the Department of Oncology, and co-leader of the Hematological Malignancies Program at St. Jude Children’s Research Hospital in Memphis, Tennessee, for his work studying the molecular definitions of childhood leukemia and of developing clinical protocols based on those findings.
Marlo Thomas, an award-winning actress, author, and activist, who also serves as the national outreach director for St. Jude Children’s Research Hospital, for her efforts to increase public awareness of childhood cancer and for her support of cancer research and care.
Robert F. Ozols, MD, PhD, who served as the first Audrey Weg Schaus and Geoffrey Alan Weg Chair in Medical Science, and as a senior vice president and chief clinical officer at Fox Chase Cancer Center In Philadelphia, Pennsylvania, until his retirement in 2008 following two decades of service at the institution, for his research on how cancer cells develop drug resistance and on strategies for overcoming resistance.
|Title||Expiration Date||CME Credits|
|34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™||May 25, 2018||2.0|
|Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast Cancer||May 30, 2018||2.0|